Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-23-000020

Chief People Officer gave up 1,301 shares (to pay taxes)

  • Chief People Officer acquired 3,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Schick Kelly · Chief People Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-30 Exercise or conversion : show line 1 in the form +3,750 6,398 D
2023-01-30 Shares withheld for taxes : show line 2 in the form −1,301 $7.78 $10,122 5,097 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-30 Exercise or conversion : show line 3 in the form Performance Restricted Stock Units −3,750 18,750 D
Loading xslF345X03/wf-form4_167528575707675.xml…